BioCis Pharma is a clinical stage drug development company with the business idea to design and develop novel pharmaceutical products based on its proprietary technology platform.
BioCis Pharma is targeting unmet medical needs in substantial therapeutic markets including inflammation, allergy, and cancer. The first products are being developed for major medical indications in dermatology, ophthalmology, and urology.
BioCis Pharma was founded in 2003 by Dr. Lasse Leino and Dr. Jarmo Laihia, two experienced research and development professionals with both industrial and scientific backgrounds.
Since the start of its operation in December 2004, BioCis Pharma has shown exceptional ability to move product candidates forward in development programmes, having now two high-potential products under clinical Phase I-II development.